GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Redhill Biopharma Ltd (STU:2RH0) » Definitions » Price-to-Tangible-Book

Redhill Biopharma (STU:2RH0) Price-to-Tangible-Book : (As of Jun. 05, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Redhill Biopharma Price-to-Tangible-Book?

As of today (2024-06-05), Redhill Biopharma's share price is €0.402. Redhill Biopharma's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was €-0.50. Hence, Redhill Biopharma's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Redhill Biopharma's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Redhill Biopharma's highest Price to Tangible Book Ratio was 5.23. The lowest was 2.75. And the median was 3.29.

STU:2RH0's Price-to-Tangible-Book is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.31
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Redhill Biopharma's share price is €0.402. Redhill Biopharma's Book Value per Sharefor the quarter that ended in Jun. 2023 was €0.81. Hence, Redhill Biopharma's P/B Ratio of today is 0.49.


Redhill Biopharma Price-to-Tangible-Book Historical Data

The historical data trend for Redhill Biopharma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redhill Biopharma Price-to-Tangible-Book Chart

Redhill Biopharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.78 - - - -

Redhill Biopharma Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Redhill Biopharma's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Redhill Biopharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Redhill Biopharma's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Redhill Biopharma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Redhill Biopharma's Price-to-Tangible-Book falls into.



Redhill Biopharma Price-to-Tangible-Book Calculation

Redhill Biopharma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Jun. 2023 )
=0.402/-0.497
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Redhill Biopharma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Redhill Biopharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Redhill Biopharma (STU:2RH0) Business Description

Traded in Other Exchanges
Address
21 Ha’arba’a Street, Tel Aviv, ISR, 6473921
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults, Talicia for the treatment of Helicobacter pylori infection in adults, and Aemcolo for the treatment of travelers' diarrhea in adults. Its key clinical late-stage development programs include RHB-104 for Crohn's disease; RHB-204, for pulmonary nontuberculous mycobacteria infections; RHB-102 (Bekinda) with positive results from a first Phase 3 study for acute gastroenteritis and gastritis; Opaganib (Yeliva); RHB-106, an encapsulated bowel preparation and RHB-107, a Phase 2-stage serine protease inhibitor targeting cancer and inflammatory gastrointestinal diseases.

Redhill Biopharma (STU:2RH0) Headlines

No Headlines